CN1166339A - Heat-clearing plaque-eliminating bolus for curing psoriasis - Google Patents
Heat-clearing plaque-eliminating bolus for curing psoriasis Download PDFInfo
- Publication number
- CN1166339A CN1166339A CN 96115334 CN96115334A CN1166339A CN 1166339 A CN1166339 A CN 1166339A CN 96115334 CN96115334 CN 96115334 CN 96115334 A CN96115334 A CN 96115334A CN 1166339 A CN1166339 A CN 1166339A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- replace
- heat
- psoriatic
- processing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The blous is a honeyed on prepared with crushed Coptidis, roasted Rhizoma pinelliae, frankincense and myrrh as chief medicinal material. The said medicine is used for treating psoriasis by eliminating white scurf and red skin plaque, and it has higher cure rate and effective rate and shorter cure period to spot type psoriasis.
Description
The present invention relates to a kind of curing psoriasis medicine that is difficult to control---treat psoriatic heat-clearing plaque-eliminating bolus.
Present domestic medical profession lacks good Therapeutic Method to psoriatic treatment, modern medicine adopts hormones, antitumor class and the immunosuppressant treatment should disease, make auxiliary treatment with vitamin, for example the normal bimolane sheet that adopts of doctor trained in Western medicine is treated this disease, and its therapeutic dose and toxic dose are very approaching, and skin lesion disappears after the medication, the drug withdrawal skin lesion recurs at once, and more serious before of the skin lesion after the recurrence than medication, the essential escalated dose of the same medicine of reuse, thus very easily poison.And the traditional Chinese medical science thinks that onset of psoriasis mechanism is heat in blood, blood deficiency, blood stasis at present, the Therapeutic Principle who adopts is that clearing away heat and cooling blood, blood enriching and dryness moistening, heat-clearing and toxic substances removing, removing heat from blood and promoting blood circulation are antipruritic in loosing, useful clinically KEYIN PIAN, compound recipe Indigo Naturalis ball, wherein the main component of KEYIN PIAN is the Radix Rehmanniae, the main component of compound recipe Indigo Naturalis ball is favus skin and Rhizoma Smilacis Glabrae, therapeutic effect is undesirable, pay a return visit among 28 patients through actual, there are 12 examples invalid with the patient of compound recipe Indigo Naturalis ball, and KEYIN PIAN is not used now because clinical effectiveness is not good.
The purpose of this invention is to provide a kind of method and psoriatic heat-clearing plaque-eliminating bolus of its treatment that better curative effect is arranged that adopts the removing heat-phlegm promoting flow of QI and blood.
The object of the present invention is achieved like this: it is considered herein that psoriatic pathogeny is damp and hot, expectorant, blood stasis, the three is assorted forms to smouldering skin, the present invention adopts following scheme from this mechanism: treat psoriatic heat-clearing plaque-eliminating bolus, its prescription is formed and is comprised: (is 1 part in the weight of processing the Rhizoma Pinelliae)
Rhizoma Coptidis: 1.67-2
Process the Rhizoma Pinelliae: 1
Olibanum Myrrha: 1-1.5
The present invention is through following steps: above-mentioned each medicine is ground into fine powder, becomes ball with processed with honey.
Why the present invention thinks that psoriatic pathogeny is damp and hot, expectorant, blood stasis, the three is assorted forms to smouldering skin, it is clinical practice through more than ten years, further studied intensively theory of Chinese medical science again, psoriatic skin lesion is carried out dialectical Analyses: psoriatic skin lesion is once betide that skin surface is fixing not to be moved, and is indefinite irrelevant with the migration of traditional Chinese medical science wind being mobile and changeable; Psoriatic skin lesion substrate is hardened with the ratio normal skin that hands touches, and is a flat irregular speckle, and traditional Chinese medical science tuberosity speckle is relevant with the expectorant stasis of blood." surgery open profound bright skin infection itch the numb opinion of pain " medium cloud, " all sufferings skin infection persons belong to heart-fire, lid fire be thing, bright all things on earth can disappear; so dilapdated and ruined all kinds of matters is also; to burn then be skin ulcer to fire near lid people's the skin, closely fire is littlely far then itched then bitterly; ... through the cloud pain being considered as excess in nature; itching being considered as a deficient symptom, non-is the void of deficiency and coldness, is that intimately little meaning very is also ".Psoriatic in a word itching by due to the heat, adopt removing heat-phlegm promoting flow of QI and blood method to form the present invention from the present invention of this mechanism, Rhizoma Coptidis in the prescription plays the clearing away heat-damp and promoting diuresis effect, processing the Rhizoma Pinelliae reduces phlegm, the Olibanum Myrrha plays function of promoting blood circulation to disperse blood clots, Fructus Aurantii, Radix Platycodonis, Pericarpium Citri Reticulatae plays the circulation of qi promoting effect, and Fructus Trichosanthis, Semen Raphani, Fructus Perillae, Radix Platycodonis plays resolve phlegm effect, Radix Gentianae and Radix Scutellariae play the clearing away heat-damp and promoting diuresis effect, making has removing heat-phlegm on the integral formulation, the effect of promoting flow of QI and blood, thereby skin lesion is disappeared, and wherein the disappearance of drop shape and silver coin shape is faster, and can cure (be one month a course of treatment) course of treatment of general drop shape, can cure about general two courses of treatment of silver coin shape, disappearance slower of ground figure, begin effectively general two courses of treatment, and efficacy determination is pressed following standard:
1, recovery from illness standard: skin lesion all disappear (the skin lesion place leaves depigmentation speckle and pigmentation spots)
2, effective standard: skin lesion substrate color is transferred to scarlet or is transferred to light redly by scarlet by dark red, and white scales comes off a small amount of or disappears, and skin lesion disappears 1/2.
3, invalid standard: the skin lesion base coat colour white scales what with medication not before the same, the no change person.
All nontoxic in all pharmaceutical formulations of the present invention.
Model case:
1, appointed the new man of generation 24 years old, favor people from shop, Yingkou City suffers from psoriasis punctata, and ill first quarter moon is taken medicine 40 balls of the present invention (every ball 9 grams) every day three times, each ball, recovery from illness.
2, Jiang Wen show woman is 56 years old, and silver coin shape psoriasis is suffered from the work of old limit grain and oil company in Yingkou, 15 years ill phases, once use KEYIN PIAN, compound recipe Indigo Naturalis ball invalid, took medicine 260 balls of the present invention, twice of every day, each ball, near recovery from illness, eat pheasant after, it is heavy that the state of an illness becomes, take medicine 90 balls of the present invention again, be almost recovered.
3, the Xu Zhen man is 31 years old, and psoriasis punctata is suffered from the work of three friendly pharmaceutcal corporation, Ltds in the Yingkou City, takes medicine 100 balls of the present invention in ill about 2 years, every day three times, and one time one ball, the recovery from illness course of treatment, the recovery from illness of 70 balls is obeyed in slightly recurrence after 3 years.
4, Liu Hong roc man is 63 years old, and work is done in people's air defense in the Yingkou City, suffers from ground figure psoriasis, and ill 20 years, it was invalid to take multiple medicine in the period of 20, takes this medicine 220 balls, the recovery from illness of head skin lesion, and not recurrence, the skin lesion at other positions alleviates.
28 examples of paying a return visit are taken medicine patient of the present invention, 23 example recoveries from illness, 27 examples effectively, 1 example is invalid, wherein 12 by namely takes the invalid patient of compound recipe Indigo Naturalis ball, recurrent interval time is longer, the recurrence disease alleviates.
The present invention removes can treat psoriasis, also can be used for treating seborrheic dermatitis and subacute and chronic eczema, and can be used for treating rosacea.
Be described in detail technical solution of the present invention below.
The weight ratio of prescription each component is among the embodiment: (is 1 part in the weight of processing the Rhizoma Pinelliae)
Embodiment 1 embodiment 2 embodiment 3 Rhizoma Coptidis 1.67 2 1.8 are processed the Rhizoma Pinelliae 111 Olibanum Myrrhas 1 1.5 1.3
Embodiment 4 embodiment 5 embodiment 6
Radix Scutellariae 1.5 1 1.3
Radix Gentianae 2 0.67 1.4
Rhizoma Coptidis 2 1.67 1.8
Rhizoma Atractylodis 1 0.67 0.8
Process the Rhizoma Pinelliae 111
Fructus Trichosanthis 1.5 1 1.2
Semen Raphani 1.5 1 1.3
Poria 1.5 1 1.3
Fructus Aurantii 1.5 1 1.3
Radix Platycodonis 1.5 1 1.2
Pericarpium Citri Reticulatae 1 0.75 0.9
Olibanum Myrrha 1.5 1 1.3
Radix Glycyrrhizae 1 0.67 0.8
Fructus Perillae 1 0.67 0.8
Embodiment 7:
Rhizoma Coptidis among the embodiment 1,2,3,4,5,6 can replace with Cortex Phellodendri, and every part of Rhizoma Coptidis can replace with the Cortex Phellodendri of 1.5 parts, 1.8 parts or 2 parts.
Embodiment 8:
Rhizoma Coptidis among the embodiment 1,2,3,4,5,6 also can replace with Radix Scutellariae, and every part of Rhizoma Coptidis can replace with the Radix Scutellariae of 1.5 parts, 1.8 parts or 2 parts.
Embodiment 9:
Rhizoma Coptidis among the embodiment 1,2,3,4,5,6 can also replace with Fructus Gardeniae, every part of Rhizoma Coptidis can with 1.5 parts, 2 parts or 2.5 parts Fructus Gardeniae replace.
Embodiment 10:
Processing the Rhizoma Pinelliae and can replace with Arisaema Cum Bile (or processing Rhizoma Arisaematis) among the embodiment 1,2,3,4,5,6, processing the Rhizoma Pinelliae for every part can be with Arisaema Cum Bile (or processing Rhizoma Arisaematis) replacement of same umber.
Embodiment 11:
The also available Semen Armeniacae Amarum of the Rhizoma Pinelliae of processing among the embodiment 1,2,3,4,5,6 replaces, and processs the Rhizoma Pinelliae with 1 part, 1.2 parts or 1.5 parts of Semen Armeniacae Amarums replacements for every part.
Embodiment 12:
The also available Fructus Trichosanthis of the Rhizoma Pinelliae of processing among the embodiment 1,2,3,4,5,6 replaces, and processs 1 part of the Rhizoma Pinelliae, 1.5 parts or 2 parts of Fructus Trichosanthis replacements for every part.
Embodiment 13:
The also available Semen Raphani of the Rhizoma Pinelliae of processing among the embodiment 1,2,3,4,5,6 replaces, every part of Semen Raphani replacement of processing the Rhizoma Pinelliae with 1 part, 1.5 parts or 2 parts.
Embodiment 14:
Olibanum Myrrha among the embodiment 1,2,3,4,5,6 can replace with the Semen Persicae or the Flos Carthami of equivalent.
Embodiment 15:
Olibanum Myrrha among the embodiment 7,8, the 9 also Semen Persicae or the Flos Carthami of available equivalent replaces.
Embodiment 16:
Olibanum Myrrha among the embodiment 10,11,12, the 13 also Semen Persicae or the Flos Carthami of available equivalent replaces.
Embodiment 17:
Processing the Rhizoma Pinelliae, Rhizoma Coptidis and can be substituted by other composition simultaneously among the embodiment 1,2,3,4,5,6, every part of Rhizoma Coptidis can replace with the Cortex Phellodendri or the Radix Scutellariae of 1.5 parts, 1.8 parts or 2 parts, or replace with the Fructus Gardeniae of 1.5 parts, 2 parts or 2.5 parts, processing the Rhizoma Pinelliae for every part replaces with same Arisaema Cum Bile (or processing Rhizoma Arisaematis), or replace with 1 part, 1.2 parts or 1.5 parts of Semen Armeniacae Amarums, or replace, or with the Semen Raphani replacement of 1 part, 1.5 parts or 2 parts with 1 part, 1.5 parts or 2 parts of Fructus Trichosanthis.
Embodiment 18:
Processing the Rhizoma Pinelliae, Rhizoma Coptidis, Olibanum Myrrha and can be replaced by other composition simultaneously among the embodiment 1,2,3,4,5,6, every part of Rhizoma Coptidis can replace with the Cortex Phellodendri or the Radix Scutellariae of 1.5 parts, 1.8 parts or 2 parts, or replace with the Fructus Gardeniae of 1.5 parts, 2 parts or 2.5 parts, processing the Rhizoma Pinelliae for every part can replace with same Arisaema Cum Bile (or processing Rhizoma Arisaematis), or replace with 1 part, 1.2 parts or 1.5 parts of Semen Armeniacae Amarums, or replace with 1 part, 1.5 parts or 2 parts of Fructus Trichosanthis, or replace with the Semen Raphani of 1 part, 1.5 parts or 2 parts, every part of Olibanum Myrrha replaces with the Semen Persicae or the Flos Carthami of equivalent.
Embodiment 19:
Fructus Aurantii among the embodiment 4,5,6 can replace with Fructus Aurantii Immaturus, and Pericarpium Citri Reticulatae can replace with Pericarpium Citri Reticulatae Viride, and the two can also can be replaced respectively simultaneously, and every part of Fructus Aurantii replaces with 0.75 part of Fructus Aurantii Immaturus, and every part of Pericarpium Citri Reticulatae replaces with 0.75 part of Pericarpium Citri Reticulatae Viride.
The processing technology of the various embodiments described above is as follows: each medicine is ground into fine powder, becomes ball with processed with honey.
Claims (10)
1, the psoriatic heat-clearing plaque-eliminating bolus of a kind of treatment is characterized in that its prescription composition comprises: (is 1 part in the weight of processing the Rhizoma Pinelliae)
Rhizoma Coptidis: 1.67-2
Process the Rhizoma Pinelliae: 1
Olibanum Myrrha: 1-1.5
2, the psoriatic heat-clearing plaque-eliminating bolus of treatment according to claim 1 is characterized in that its prescription composition comprises: (is 1 part in the weight of processing the Rhizoma Pinelliae)
Radix Scutellariae: 1-1.5
Radix Gentianae: 0.67-2
Rhizoma Coptidis: 1.67-2
Rhizoma Atractylodis: 0.67-1
Process the Rhizoma Pinelliae: 1
Fructus Trichosanthis: 1-1.5
Semen Raphani: 1-1.5
Poria: 1-1.5
Fructus Aurantii: 1-1.5
Radix Platycodonis: 1-1.5
Pericarpium Citri Reticulatae: 0.75-1
Olibanum Myrrha: 1-1.5
Radix Glycyrrhizae: 0.67-1
Fructus Perillae: 0.67-1.
3, the psoriatic heat-clearing plaque-eliminating bolus of treatment according to claim 1 and 2, it is characterized in that Rhizoma Coptidis can use Cortex Phellodendri, Fructus Gardeniae or Radix Scutellariae to replace in its prescription composition, every part of Rhizoma Coptidis can replace with the Cortex Phellodendri or the Radix Scutellariae of (1.5-2) part, also available (1.5-2.5) part Fructus Gardeniae replace.
4, the psoriatic heat-clearing plaque-eliminating bolus of treatment according to claim 1 and 2, it is characterized in that the process Rhizoma Pinelliae of its prescription in forming can be with Arisaema Cum Bile (or processing Rhizoma Arisaematis), Semen Armeniacae Amarum, Fructus Trichosanthis or Semen Raphani replacement, processing the Rhizoma Pinelliae for every part can be with same Arisaema Cum Bile (or processing Rhizoma Arisaematis), or (1-1.5) part Semen Armeniacae Amarum, or (1-2) part Fructus Trichosanthis replacement, the Semen Raphani of also available (1-2) part replaces.
5, the psoriatic heat-clearing plaque-eliminating bolus of treatment according to claim 1 and 2 is characterized in that the Olibanum Myrrha in its prescription composition can replace with the Semen Persicae or the Flos Carthami of equivalent.
6, the psoriatic heat-clearing plaque-eliminating bolus of treatment according to claim 3 is characterized in that the Olibanum Myrrha in its prescription composition can replace with the Semen Persicae or the Flos Carthami of equivalent.
7, the psoriatic heat-clearing plaque-eliminating bolus of treatment according to claim 4 is characterized in that the Olibanum Myrrha in its prescription composition can replace with the Semen Persicae or the Flos Carthami of equivalent.
8, the psoriatic heat-clearing plaque-eliminating bolus of treatment according to claim 1 and 2, it is characterized in that its prescription in forming process the Rhizoma Pinelliae, Rhizoma Coptidis can be simultaneously replaced, every part of Rhizoma Coptidis can replace with the Cortex Phellodendri or the Radix Scutellariae of (1.5-2) part, the Fructus Gardeniae of also available (1.5-2.5) part replaces, processing the Rhizoma Pinelliae for every part can be with same Arisaema Cum Bile (or processing Rhizoma Arisaematis), or (1-1.5) part Semen Armeniacae Amarum, or (1-2) part Fructus Trichosanthis replaces, the Semen Raphani of also available (1-2) part replaces.
9, the psoriatic heat-clearing plaque-eliminating bolus of treatment according to claim 1 and 2, it is characterized in that its prescription processing the Rhizoma Pinelliae, Rhizoma Coptidis, Olibanum Myrrha and can be replaced simultaneously in forming, every part of Rhizoma Coptidis can replace with the Cortex Phellodendri or the Radix Scutellariae of (1.5-2) part, the Fructus Gardeniae of also available (1.5-2.5) part replaces, processing the Rhizoma Pinelliae for every part can be with same Arisaema Cum Bile (or processing Rhizoma Arisaematis), or (1-1.5) part Semen Armeniacae Amarum, or (1-2) part Fructus Trichosanthis replacement, the Semen Raphani of also available (1-2) part replaces, and every part of Olibanum Myrrha uses the Semen Persicae of equivalent or Flos Carthami to replace.
10, the psoriatic heat-clearing plaque-eliminating bolus of treatment according to claim 2, it is characterized in that described Fructus Aurantii can replace with Fructus Aurantii Immaturus, Pericarpium Citri Reticulatae can replace with Pericarpium Citri Reticulatae Viride, and the two can also can be replaced respectively simultaneously, every part of Fructus Aurantii replaces with 0.75 part of Fructus Aurantii Immaturus, and every part of Pericarpium Citri Reticulatae replaces with 0.75 part of Pericarpium Citri Reticulatae Viride.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96115334A CN1056770C (en) | 1996-05-24 | 1996-05-24 | Heat-clearing plaque-eliminating bolus for curing psoriasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96115334A CN1056770C (en) | 1996-05-24 | 1996-05-24 | Heat-clearing plaque-eliminating bolus for curing psoriasis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1166339A true CN1166339A (en) | 1997-12-03 |
CN1056770C CN1056770C (en) | 2000-09-27 |
Family
ID=5122604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96115334A Expired - Fee Related CN1056770C (en) | 1996-05-24 | 1996-05-24 | Heat-clearing plaque-eliminating bolus for curing psoriasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1056770C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1089597C (en) * | 1998-04-01 | 2002-08-28 | 王新岭 | Psoriasis treating Chinese medicine preparation and its preparing process |
CN1301124C (en) * | 2004-11-17 | 2007-02-21 | 汤铁强 | Chinese traditional medicine liquor for treating chronic dermatopathy |
CN100352475C (en) * | 2005-11-25 | 2007-12-05 | 贾建强 | Medicine for treating psoriasis and preparing process thereof |
CN107456510A (en) * | 2017-07-11 | 2017-12-12 | 于均峰 | A kind of ointment of the treatment psoriasis based on asafoetide root extract composition |
CN108403920A (en) * | 2018-05-31 | 2018-08-17 | 段洪明 | Chinese medicine composition and the preparation method and application thereof for treating skin disease of bursting from head to foot |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9879897B2 (en) | 2010-12-02 | 2018-01-30 | Frosty Cold, Llc | Cooling agent for cold packs and food and beverage containers |
-
1996
- 1996-05-24 CN CN96115334A patent/CN1056770C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1089597C (en) * | 1998-04-01 | 2002-08-28 | 王新岭 | Psoriasis treating Chinese medicine preparation and its preparing process |
CN1301124C (en) * | 2004-11-17 | 2007-02-21 | 汤铁强 | Chinese traditional medicine liquor for treating chronic dermatopathy |
CN100352475C (en) * | 2005-11-25 | 2007-12-05 | 贾建强 | Medicine for treating psoriasis and preparing process thereof |
CN107456510A (en) * | 2017-07-11 | 2017-12-12 | 于均峰 | A kind of ointment of the treatment psoriasis based on asafoetide root extract composition |
CN108403920A (en) * | 2018-05-31 | 2018-08-17 | 段洪明 | Chinese medicine composition and the preparation method and application thereof for treating skin disease of bursting from head to foot |
Also Published As
Publication number | Publication date |
---|---|
CN1056770C (en) | 2000-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1129577A (en) | Pellets for curing tinea | |
CN1079253C (en) | Medicinal oil for dredging channels and collaterals of heart and brain and its preparing process | |
CN1056770C (en) | Heat-clearing plaque-eliminating bolus for curing psoriasis | |
CN1785370A (en) | Medicine for treating facial paralysis spasm | |
CN1140278C (en) | Nephrolithiasis treating medicine | |
CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
CN1476884A (en) | Inflammation-relieving plaster and its production method | |
CN1134837A (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
CN1225254C (en) | Medicinal composition, its preparation process and use in treating psoriasis | |
CN1094057C (en) | Liver ascites treating medicine | |
CN1319587C (en) | Medicine powder for liver and spleen diseases | |
CN1107711A (en) | Hypoglycemic compound capsule | |
CN1083714A (en) | A kind of cancer therapy drug of Chinese medicinal components | |
CN1180794C (en) | Gallbladder and appendix antiphlogistic | |
CN1061252C (en) | Preparation of Chinese medicine for curing cardiac and cerebral diseases atomized by oxygen and its preparation process | |
CN1449773A (en) | Chinese patent drug for treating gastric ulcer and its preparation method | |
CN1058631C (en) | Psoriasis capsule | |
CN1298375C (en) | Medicine for treating psoriasis | |
CN1401345A (en) | Medicine for treating athlete's foot for external use and producing method thereof | |
CN1076622C (en) | Chinese medicine for curing nephritis | |
CN1149096C (en) | Medicine for treating drug-fast tuberculosis | |
CN1296091C (en) | Chinese traditional medicine composition for treating psoriasis | |
CN1352966A (en) | Medicine for treating tracheitis and asthma | |
CN100350957C (en) | Composition for curing psoriasis | |
CN1268374C (en) | Medicine for treating psoriasis and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |